Accessibility Versus Quality of Care Plus Retention: The Formula for Service Delivery in Australian Opioid Replacement Therapy?

REFERENCES

• Australian Capital Territory Health. (2010). The ACT opioid maintenance treatment guidelines. Canberra: ACT Government.
   Google Scholar
• Al-Tayyib, A. A., & Koester, S. (2011). Injection drug users’ experience with and attitudes toward methadone clinics in Denver, CO. Journal of Substance Abuse Treatment, 41, 30–36.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. (2006). Medical labour force. In National health labour force series. Canberra: Author.
   Google Scholar
• Australian Institute of Health and Welfare. (2010). AIHW National Hospital Morbidity Database: Seperation, patient day and average length of stay statistics by principal diagnosis in ICD-10-AM, Australia, 1998-99 to 2007-08 Canberra.
   Google Scholar
• Australian Institute of Health and Welfare. (2011a). 2010 National Drug Strategy Household Survey report. In Drug statistics series, Canberra: AIHW.
   Google Scholar
• Australian Institute of Health and Welfare. (2011b). Alcohol and other drug treatment services national minimum data set 2011-12. Canberra: AIHW.
   Google Scholar
• Australian Institute of Health and Welfare. (2012a). National Opioid Pharmacotherapy Statistics Annual Data 2012 collection: Data Guide. Canberra: AIHW.
   Google Scholar
• Australian Institute of Health and Welfare. (2012b). National Opioid Pharmacotherapy Statistics Annual Data collection: 2011 report. Canberra: AIHW.
   Google Scholar
• Banta-Green, C. J., Maynard, C., Koepsell, T. D., Wells, E. A., & Donovan, D. M. (2009). Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Addiction, 104(5), 775–783.
   PubMed Web of Science ®Google Scholar
• Brands, B., Blake, J., Marsh, D. C., Sproule, B., Jeyapalan, R., & Li, S. (2008). The impact of benzodiazepine use on methadone maintenance treatment outcomes. Journal of Addictive Diseases, 27(37–48).
   PubMedGoogle Scholar
• Brener, L., Hippel, W. V., Kippax, S., & Preacher, K. J. (2010). The role of physician and nurse attitudes in the health care of injecting drug users. Substance Use & Misuse, 45(7–8), 1007–1018.
   PubMed Web of Science ®Google Scholar
• Brown, L., Albert, M., Binion-Taylor, T., Brady, T., Jackson, R., Juliana, P., … Willis, T. (2007). Guidelines for the accreditation of opioid treatment programs. edited by Substance Abuse and Mental Health Services Administration. Rockville, MD: Victorian Government.
   Google Scholar
• Burns, L., Randall, D., Hall, W. D., Law, M., Butler, T., Bell, J., & Degenhardt, L. (2009). Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention. Addiction, 104(4), 1363–1372.
   PubMedGoogle Scholar
• Centre for Substance Abuse Treatment. (2004). Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction: Treatment Improvement Protocol 40. Rockville: Substance Abuse and Mental Health Administration.
   Google Scholar
• Chalmers, J., Ritter, A., Heffernan, M., & McDonnell, G. (2009). Modelling pharmacotherapy maintenance in Australia: Exploring affordability, availability, accessibility and quality using system dynamics. edited by Drug Policy Modelling Program University of New South Wales: Australian National Council on Drugs.
   Google Scholar
• Cresswell, J. (2008). Drug addicts turned away from stretched methadone clinic, 22nd October 2008.
   Google Scholar
• Dawe, S., Frye, S., Best, D., Moss, D., Atkinson, J., Evans, C., … Harnett, P. (2006). Drug use in the family impacts and implications for children. Canberra: Australian National Council on Drugs.
   Google Scholar
• Day, E., Best, D., Copello, A., Young, H., Khoosal, N., & Modern, N. (2008). Characteristics of drug-using patients and treatment provided in primary and secondary settings. Journal of Substance Use, 13(1), 27–35.
   Web of Science ®Google Scholar
• De Alba, I., Samet, J. H., & Saitz, R. (2004). Burden of medical Illness in drug and alcohol dependent persons without primary care. The American Journal on Addictions, (13), 33–45.
   PubMedGoogle Scholar
• De Maeyer, J., Vanderplasschen, W., Camfield, L., Vanheule, S., Sabbe, B., & Broekaert, E. (2011). A good quality of life under the influence of methadone: A qualitative study among opiate-dependent individuals. International Journal of Nursing Studies, 48, 1244–1257.
   PubMed Web of Science ®Google Scholar
• Department of Health (England) and devolved administrations. (2007). Drug misuse and dependence: UK guidelines on clinical management. edited by t. S. G. Department of Health (England), Welsh Assembly Government and Northern Ireland Executive. London.
   Google Scholar
• Donny, E. C., Brasser, S. M., Bigelow, G. E., Stitzer, M. L., & Walsh, S. L. (2005). Methadone doses of 100mg or greater are more effective than lower doses at suppressing heroin self administration in opioid-dependent volunteers. Addiction, (100), 1496–1509.
   PubMedGoogle Scholar
• Drug and Alcohol Office. (2007). Western Australia: Clinical policies and procedures for the use of methadone and buprenorphine in the treatment of opioid dependence. Mt Lawley: Drug and Alcohol Office.
   Google Scholar
• Drug and Alcohol Office. (Ed.). (2012). Measuring Outcomes – ATOP – Jennifer Holmes, NSW Health. Perth: Government of Western Australia.
   Google Scholar
• Drugs of Dependence Unit. (2012). DDU Information Circular: Interim arrangement for patients pending admission to QOTP. Herston, Queensland: DDU.
   Google Scholar
• Drugs Of Dependence Unit Queensland. (2012). Queensland opioid treatment program: Clinical guidelines. Herston, Queensland: DDU.
   Google Scholar
• Duncan, B. (2012). A rising tide. Of Substance: The National Magazine on Alcohol, Tobacco and Other Drugs, 20–23.
   Google Scholar
• Ford, C., Halliday, K., Lawson, E., & Browne, E. (2011). Guidance for the use of substitute prescribing in the treatment of opioid dependence in primary care. London: Royal College of General Practitioners.
   Google Scholar
• Friedmann, P. D., Hoskinson, R., Gordon, M., Schwartz, R., Kinlock, T., Knight, K., … M. A. T. Working Group of C. J. Dats for the. (2011). Medication-assisted treatment in Criminal Justice Agencies affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, barriers, and intentions. Substance Abuse, 33(1), 9–18.
   Google Scholar
• Frye, S., Dawe, S., Harnett, P., Kowalenko, S., & Harlen, M. (2008). Supporting the families of young people with problematic drug use: Investigating support options. Civic Square: Australian National Council on Drugs.
   Google Scholar
• Gill, T. (2008). Review of opioid treatment in Queensland. Brisbane.
   Google Scholar
• Gjersing, L., Waal, H., Caplehorn, J. R. M., Gossop, M., & Clausen, T. (2010). Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment. BMC Health Services Research, 10, 94.
   Google Scholar
• Gossop, M., Stewart, D., Browne, N., & Marsden, J. (2003). Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: Outcomes at 2-year follow-up. Journal of Substance Abuse Treatment, 24, 313–321.
   PubMed Web of Science ®Google Scholar
• Gryczynski, J., Schwartz, R. P., Salkever, D. S., Mitchell, S. G., & Jaffe, J. H. (2011). Patterns in admission delays to outpatient methadone treatment in the United States. Journal of Substance Abuse Treatment, 41, 431–439.
   PubMed Web of Science ®Google Scholar
• Guarino, H. M., Marsch, L. A., Campbell, W. S., Gargano, S. P., Haller, D. L., & Solhkhah, R. (2009). Methadone maintenance treatment for youth: Experiences of clients, staff and parents. Substance Use & Misuse, 44(14), 1979–1989.
   PubMed Web of Science ®Google Scholar
• Hallinan, R., Osborn, M., Cohen, M., Dobbin, M., & Wodak, A. (2011). Increasing the benefits and reducing the harms of prescription opioid analgesics. Drug and Alcohol Review, 30, 315–323.
   PubMedGoogle Scholar
• Harlow, W., Happell, B., & Browne, G. (2011). Opioid replacement therapy: A wait unmanaged. International Journal of Mental Health Nursing, 20(6), 418–427.
   PubMed Web of Science ®Google Scholar
• Humphreys, K., & McLellan, A. T. (2011). A policy-oriented review of strategies for improving the outcomes of services for substance use disorder patients. Addiction, 106, 2058–2066.
   PubMed Web of Science ®Google Scholar
• Intergovernmental Committee on Drugs. (2007). National pharmacotherapy policy: For people dependant on opioids. Canberra: Intergovernmental Committee on Drugs, Australian Government.
   Google Scholar
• Karow, A., Reimer, J., Schäfer, I., Krausz, M., Haasen, C., & Verthein, U. (2010). Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence. Drug and Alcohol Dependence, 112(3), 209–215.
   PubMed Web of Science ®Google Scholar
• Kimber, J., Copeland, L., Hickman, M., Macleod, J., McKenzie, J., De Angelis, D., & Robertson, J. R. (2010). Survival and cessation in injecting drug users: Prospective observational study of outcomes and effect of opiate substitution treatment. British Medical Journal, 341, c3172.
   PubMed Web of Science ®Google Scholar
• Kratzmann, M., Mitchell, E., Ware, J., Banach, L., Ward, J., & Ryan, J. (2011). Injecting drug use and associated harms among Aboriginal Australians. Canberra: Australian National Council on Drugs.
   Google Scholar
• Laudet, A. B., Becker, J. B., & White, W. L. (2009). Don't wanna go through that madness no more: Quality of life satisfaction as predictor of sustained remission from illicit drug misuse. Journal of Substance Misuse, 44(2), 227–252.
   Google Scholar
• Leong, M., Murnion, B., & Haber, P. S. (2009). Examination of opioid prescribing in Australia from 1992 to 2007. Internal Medicine Journal, 39(10), 676–681.
   PubMed Web of Science ®Google Scholar
• Lind, B., Chen, S., Weatherburn, D., & Mattick, R. (2004). The effectiveness of methadone maintenance treatment in controlling crime: An aggregate-level analysis. The British Journal of Criminology, 45(2), 201–211.
   Google Scholar
• Lingford-Hughes, A. R., Welch, S., Peters, L., & Nutt, D. J. (2012). BAP updated guidelines: Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. Journal of Psychopharmacology, 1–54.
   Google Scholar
• Lintzeris, N. (2009). Prescribed medications: The new wave of opioid dependence. Of Substance: The National Magazine on Alcohol, Tobacco and Other Drugs, 10–11.
   Google Scholar
• Lloyd, B. K., & Mcelwee, P. R. (2011). Trends over time in characteristics of pharmaceutical drug-related ambulance attendances in Melbourne. Drug and Alcohol Review, 30(3), 271–280.
   PubMed Web of Science ®Google Scholar
• Matusow, H., Dickman, S. L., Rich, J. D., Fong, C., Dumont, D. M., Hardin, C., … Rosenblum, A. (2013). Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes. Journal of Substance Abuse Treatment, 44(5), 473–480.
   PubMed Web of Science ®Google Scholar
• Mental Health and Drug & Alcohol Office. (2006). New South Wales Opioid Treatment Program: clinical guidelines for methadone and buprenorphine treatment of opioid dependence. North Sydney: NSW Department of Health.
   Google Scholar
• Mills, K. L., Deady, M., Proudfoot, H., Sannibale, C., Teesson, M., Mattick, R., & Burns, L. (2010). Guidelines on the management of co-occuring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings. edited by Department of Health and Ageing. Sydney: National Drug and Alcohol Research Centre University of New South Wales.
   Google Scholar
• Ministerial Council on Drug Strategy. (2011). The national drug strategy 2010–2015: A framework for action on alcohol, tobacco, and other drugs. Canberra: Commonwealth of Australia.
   Google Scholar
• National Collaborating Centre for Mental Health. (2007). Drug misuse: Opioid detoxification. London: National Institute for Health and Clinical Excellence.
   Google Scholar
• National Institute on Drug Abuse. (2009). In N. I. o. Health (Ed.), Principals of drug addiction treatment: A research-based guide (2nd ed.). Washington, DC: U.S. Department of health and Human Services.
   Google Scholar
• National Treatment Agency for Substance Misuse. (2006). Models of care for treatment of adult drug misusers: updated 2006. London: NTA.
   Google Scholar
• National Treatment Agency for Substance Misuse. (2012a). Drug treatment 2012: progress made, challenges ahead. London: NTA.
   Google Scholar
• National Treatment Agency for Substance Misuse. (2012b). Medications in recovery: Re-orientating drug dependence treatment. London: NTA.
   Google Scholar
• Nyhlén, A., Fridell, M., Bäckström, M., Hesse, M., & Krantz, P. (2011). Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970–2006. BMC Psychiatry, 11(122), 1–9.
   PubMedGoogle Scholar
• Oliva, E. M., Harris, A. H. S., Trafton, J. A., & Gordon, A. J. (2012). Receipt of opioid agonist treatment in the Veterans Health Administration: Facility and patient factors. Drug and Alcohol Dependence, 122 (3), 241–246.
   PubMed Web of Science ®Google Scholar
• Oliva, E. M., Trafton, J. A., Harris, A. H. S., & Gordon, A. J. (2013). Trends in opioid agonist therapy in the Veterans Health Administration: Is supply keeping up with demand? The American Journal of Drug and Alcohol Abuse, 39(2), 103–107.
   PubMed Web of Science ®Google Scholar
• Oliver, P., Keen, J., Rowse, G., Ewins, E., Griffiths, L., & Mathers, N. (2009). The effect of time spent in treatment and dropout status on rates of convictions, cautions and imprisonment over 5 years in a primary care-led methadone maintenance service. Addiction, 105, 372–379.
   Web of Science ®Google Scholar
• Peterson, J. A., Schwartz, R. P., Mitchell, S. G., Reisinger, H. S., Kelly, S. M., O’Grady, K. E., … Agar, M. H. (2010). Why don't out-of-treatment individuals enter methadone treatment programmes? International Journal of Drug Policy, 21, 36–42.
   PubMed Web of Science ®Google Scholar
• Queensland Health. (1995). Queensland methadone program: Policy, procedures and treatment manual. edited by Alcohol and Drug Branch & Brisbane North Alcohol and Drug Services. Brisbane: Queensland Health.
   Google Scholar
• Riddle, R., Shanahan, M., Roxburgh, A., & Degenhardt, L. (2007). The cost of drug-related hospital stays in Australia, 1999–2005. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
   Google Scholar
• Ritter, A., & Chalmers, J. (2009). Polygon: The many sides to the Australian opioid pharmacotherapy maintenance system. In Drug policy modelling program. Civic Square, ACT: University of New South Wales.
   Google Scholar
• Roe, B., Beynon, C., Pickering, L., & Duffy, P. (2010). Experiences of drug use and ageing: health, quality of life, relationship and service implications. Journal of Advanced Nursing, 66(9), 1968–1979.
   PubMed Web of Science ®Google Scholar
• Roxburgh, A., Bruno, R., Larance, B., & Burns, L. (2011). Prescription of opioid analgesics and related harms in Australia. Medical Journal Australia, 195(5), 280–284.
   PubMed Web of Science ®Google Scholar
• Scarbourgh, J., Elliott, J., & Braunack-Mayer, A. (2011). Opioid substitution therapy: A study of GP participation in prescribing. Australian Family, 40(4), 241–245.
   PubMedGoogle Scholar
• Strang, J. (2011). Recovery-orientated Drug Treatment An interim report by Professor John Strang, chair of the expert group. edited by The National Treatment Agency for Substance Misuse. London: National Health Service.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2012). Treatment Episode Data Set (TEDS) 2009: Discharges from substance abuse treatment services. Rockville: SAMHSA.
   Google Scholar
• Teesson, M., Ross, J., Darke, S., Lynskey, M., Mills, K., Williamson, A., … Shanahan, M. (2003). Twelve month outcomes of the treatment of heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS) New South Wales. Sydney, NSW: National Drug and Alcohol Research Centre, University of New South Wales.
   Google Scholar
• The Home Office. (2010). Drug strategy 2010 reducing demand, restricting supply, buidling recovery: Supporting people to live a drug free life. London: HM Government.
   Google Scholar
• The Home Office. (2012). Drug strategy 2010. Reducing demand, restricting supply, building recovery: Supporting people to live a drug free life. Annual review. London: The Crown.
   Google Scholar
• UK Drug Policy Commission Recovery Consensus Group. (2008). Recovery consensus statement: Developing a vision of recovery. London: UK Drug Policy Commission.
   Google Scholar
• Williams, M., Greene, M., & E. Accessed May Wright, 5. (2013). Opioid Treatment Programs in Indiana. The Use of Medication in Addiction Treatment. Indianapolis The Center for Health Policy, at IUUI.
   Google Scholar
• Winstock, A., Molan, J., & Lea, T. (2008). Survey of New South Wales opioid treatment program public clinics: SWAT report 3. Sydney: National Drug and Alcohol Research Centre University of New South Wates.
   Google Scholar
• Xiao, L., Wu, L., Luo, W., & Wei, X. (2010). Quality of life of outpatients in methadone maintenance treatment clinics. Journal of Acquired Immune Deficiency Syndrome, 53(1), 116–120.
   PubMedGoogle Scholar